These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9551491)

  • 41. Synaptic dysfunction in schizophrenia.
    Yin DM; Chen YJ; Sathyamurthy A; Xiong WC; Mei L
    Adv Exp Med Biol; 2012; 970():493-516. PubMed ID: 22351070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prefrontal-limbic network in depression: Modulation by hypothalamus, basal ganglia and midbrain.
    Bennett MR
    Prog Neurobiol; 2011 Apr; 93(4):468-87. PubMed ID: 21349315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Magnetic resonance spectroscopy. Bridging the neurochemistry and neuroanatomy of schizophrenia.
    Buckley PF; Friedman L
    Br J Psychiatry; 2000 Mar; 176():203-5. PubMed ID: 10755064
    [No Abstract]   [Full Text] [Related]  

  • 44. [Investigation of the dopamine dysregulation hypothesis of schizophrenia with neuroimaging techniques].
    Szekeres G; Pávics L; Janka Z
    Ideggyogy Sz; 2002 Jul; 55(7-8):226-32. PubMed ID: 12201230
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abnormal kainate receptor expression in prefrontal cortex in schizophrenia.
    Meador-Woodruff JH; Davis KL; Haroutunian V
    Neuropsychopharmacology; 2001 May; 24(5):545-52. PubMed ID: 11282254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neuroanatomic/neuropathologic correlates in schizophrenia.
    Waldman AJ
    South Med J; 1992 Sep; 85(9):907-16. PubMed ID: 1523453
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurobiology of dopamine in schizophrenia.
    Guillin O; Abi-Dargham A; Laruelle M
    Int Rev Neurobiol; 2007; 78():1-39. PubMed ID: 17349856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence of altered calmodulin immunoreactivity in areas 9 and 32 of schizophrenic prefrontal cortex.
    Broadbelt K; Jones LB
    J Psychiatr Res; 2008 Jul; 42(8):612-21. PubMed ID: 18289558
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia.
    Meador-Woodruff JH; Haroutunian V; Powchik P; Davidson M; Davis KL; Watson SJ
    Arch Gen Psychiatry; 1997 Dec; 54(12):1089-95. PubMed ID: 9400344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Visualizing fronto-striatal circuitry and neuroleptic effects in schizophrenia.
    Buchsbaum MS; Hazlett EA; Haznedar MM; Spiegel-Cohen J; Wei TC
    Acta Psychiatr Scand Suppl; 1999; 395():129-37. PubMed ID: 10225342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic stress modulation of prefrontal cortical NMDA receptor expression disrupts limbic structure-prefrontal cortex interaction.
    Lee YA; Goto Y
    Eur J Neurosci; 2011 Aug; 34(3):426-36. PubMed ID: 21692885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and 'Schizophrenia-Like Behaviors' in Mice.
    Vitucci D; Di Giorgio A; Napolitano F; Pelosi B; Blasi G; Errico F; Attrotto MT; Gelao B; Fazio L; Taurisano P; Di Maio A; Marsili V; Pasqualetti M; Bertolino A; Usiello A
    Neuropsychopharmacology; 2016 Feb; 41(3):916-27. PubMed ID: 26228524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoamine receptors, limbic pathology and schizophrenia.
    Joyce JN
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():502A-503A. PubMed ID: 1323403
    [No Abstract]   [Full Text] [Related]  

  • 54. Reduction of synapsin III in the prefrontal cortex of individuals with schizophrenia.
    Porton B; Wetsel WC
    Schizophr Res; 2007 Aug; 94(1-3):366-70. PubMed ID: 17540541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distribution of beta-adrenergic receptor subtypes in human post-mortem brain: alterations in limbic regions of schizophrenics.
    Joyce JN; Lexow N; Kim SJ; Artymyshyn R; Senzon S; Lawrence D; Cassanova MF; Kleinman JE; Bird ED; Winokur A
    Synapse; 1992 Mar; 10(3):228-46. PubMed ID: 1313605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
    de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
    Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics.
    Healy DJ; Haroutunian V; Powchik P; Davidson M; Davis KL; Watson SJ; Meador-Woodruff JH
    Neuropsychopharmacology; 1998 Oct; 19(4):278-86. PubMed ID: 9718591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA methylation state of BDNF gene is not altered in prefrontal cortex and striatum of schizophrenia subjects.
    Keller S; Errico F; Zarrilli F; Florio E; Punzo D; Mansueto S; Angrisano T; Pero R; Lembo F; Castaldo G; Usiello A; Chiariotti L
    Psychiatry Res; 2014 Dec; 220(3):1147-50. PubMed ID: 25219617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia.
    Bertolino A; Breier A; Callicott JH; Adler C; Mattay VS; Shapiro M; Frank JA; Pickar D; Weinberger DR
    Neuropsychopharmacology; 2000 Feb; 22(2):125-32. PubMed ID: 10649825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia.
    Abi-Dargham A; Moore H
    Neuroscientist; 2003 Oct; 9(5):404-16. PubMed ID: 14580124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.